English | Español

Biospace
+ Pharmaceuticals
Patient Daily | Dec 9, 2025

Early-stage biotech firms urged to address tariff risks in planning
+ Pharmaceuticals
Patient Daily | Dec 9, 2025

Harmony's EPX-100 reduces seizures by half in Dravet syndrome Phase III trial
+ Pharmaceuticals
Patient Daily | Dec 9, 2025

Pharma explores learning from China's R&D efficiencies amid growing licensing deals
+ Pharmaceuticals
Patient Daily | Dec 9, 2025

FDA prepares major drug approval decisions for BMS, GSK, Amgen and others
+ Pharmaceuticals
Patient Daily | Dec 9, 2025

Protego Biopharma raises $130M series B for pivotal amyloidosis drug trial
+ Pharmaceuticals
Patient Daily | Dec 9, 2025

Building next-generation biologics relies on AI integration and automation advances
+ Pharmaceuticals
Patient Daily | Dec 9, 2025

FDA extends review period for Ascendis Pharma's dwarfism drug TransCon CNP
+ Pharmaceuticals
Patient Daily | Dec 9, 2025

Regeneron partners with Tessera Therapeutics on gene editing therapy for AATD

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation